Innate Pharma S.A.

Innate Pharma S.A.verified

IPHYF

Price:

$1.5

Market Cap:

$112.60M

Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), a monoclonal antibody blocking C5a binding to C5aR1 ...[Read more]

Industry

Biotechnology

IPO Date

2015-06-09

Stock Exchange

OTC

Ticker

IPHYF

The Enterprise Value as of April 2026 (TTM) for Innate Pharma S.A. (IPHYF) is 107.08M

According to Innate Pharma S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 107.08M. This represents a change of 3.82% compared to the average of 103.13M of the last 4 quarters.

Innate Pharma S.A. (IPHYF) Historical Enterprise Value (quarterly & annually)

How has IPHYF Enterprise Value performed in the past?

The mean historical Enterprise Value of Innate Pharma S.A. over the last ten years is 210.10M. The current 107.08M Enterprise Value has changed 5.00% with respect to the historical average. Over the past ten years (40 quarters), IPHYF's Enterprise Value was at its highest in in the December 2015 quarter at 794.33M. The Enterprise Value was at its lowest in in the June 2009 quarter at 0.

Quarterly (TTM)
Annual

Average

210.10M

Median

163.53M

Minimum

82.56M

Maximum

616.45M

Innate Pharma S.A. (IPHYF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Innate Pharma S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 126.88%

Maximum Annual Enterprise Value = 616.45M

Minimum Annual Increase = -72.65%

Minimum Annual Enterprise Value = 82.56M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025137.54M66.60%
202482.56M-35.96%
2023128.91M-18.65%
2022158.47M-25.07%
2021211.49M126.88%
202093.22M-56.56%
2019214.61M-25.80%
2018289.21M71.56%
2017168.58M-72.65%
2016616.45M10.05%

Innate Pharma S.A. (IPHYF) Average Enterprise Value

How has IPHYF Enterprise Value performed in the past?

The current Enterprise Value of Innate Pharma S.A. (IPHYF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

116.34M

5-year avg

143.80M

10-year avg

210.10M

Innate Pharma S.A. (IPHYF) Enterprise Value vs. Peers

How is IPHYF’s Enterprise Value compared to its peers?

Innate Pharma S.A.’s Enterprise Value is greater than Botanix Pharmaceuticals Limited (52.85M), greater than NDT Pharmaceuticals Inc. (94.90M), greater than Molecular Partners AG (30.64M), less than Scancell Holdings plc (167.69M), less than Brii Biosciences Limited (249.26M), less than Ascend Wellness Holdings, Inc. (660.42M), less than JW (Cayman) Therapeutics Co. Ltd (605.07M), less than Hofseth BioCare ASA (764.02M), less than Kintor Pharmaceutical Limited (1.21B), less than Venus Medtech (Hangzhou) Inc. (745.13M),

Build a custom stock screener for Innate Pharma S.A. (IPHYF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Innate Pharma S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Innate Pharma S.A. (IPHYF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Innate Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Innate Pharma S.A.'s Enterprise Value?

What is the highest Enterprise Value for Innate Pharma S.A. (IPHYF)?

What is the 3-year average Enterprise Value for Innate Pharma S.A. (IPHYF)?

What is the 5-year average Enterprise Value for Innate Pharma S.A. (IPHYF)?

How does the current Enterprise Value for Innate Pharma S.A. (IPHYF) compare to its historical average?